VAXART (VXRT)
(Delayed Data from NSDQ)
$0.61 USD
+0.02 (2.91%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $0.62 +0.01 (2.04%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VXRT 0.61 +0.02(2.91%)
Will VXRT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VXRT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VXRT
Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus
VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?
VXRT: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Top-Ranked Stocks That Have More Than Doubled Year to Date
VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?
Bears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now
Other News for VXRT
Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8
Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session